Everything You Need to Know About Retatrutide
Retatrutide (LY3437943), developed by Eli Lilly and Company, is an investigational peptide currently not approved for human consumption and is under investigation. It works by targeting three hormone receptors: This unique triple-action mechanism makes it different from the rest of the peptides that have been developed for the treatment of various metabolic disorders. There have […]